Advertisement
Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Golden satellite insulation sparkles during test | Space photo of the day for Dec. 30, 2025 - 2Language Learning Stages: Which One Gets Your Vote?
- 3Astronomers now say the moon is eating up molecules from Earth’s atmosphere
- 4IDF strikes Shiraz petrochemical site, releases footage of attacks on Iranian air defenses
- 5Director of Swiss hospital describes the rush to treat the injured from Alpine resort bar fire
- Doctors thought he had cancer. An offhand suggestion led to a rare diagnosis.
- Step by step instructions to Pick the Right Web-based Degree Program
- Launch pad damaged as Russian rocket blasts off for space station, agency says
- Artemis II astronauts are more than halfway to the moon as they seek to break Apollo 13's record
- Venus shines at its best in spring and summer 2026 — here's what to look for
- Mickey Lee of 'Big Brother' fame dead at 35 after flu complications, family says
- UN chief calls on Yemen's Houthi rebels to free all UN detainees
- Scientists dove hundreds of feet into the ocean and found creatures no human has ever seen. Our trash beat us there
- Brazil expands pesticide packaging reverse logistics
